We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$6.49B
AUM Growth
+$522M
Cap. Flow
+$250M
Cap. Flow %
3.85%
Top 10 Hldgs %
30.81%
Holding
398
New
73
Increased
93
Reduced
91
Closed
53

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$103M
2
CMCSA icon
Comcast
CMCSA
+$103M
3
NOV icon
NOV
NOV
+$85.6M
4
CVA
Covanta Holding Corporation
CVA
+$65.7M
5
PFE icon
Pfizer
PFE
+$62.2M

Sector Composition

Rank Sector Weight
1 Financials 15.96%
2 Healthcare 15.4%
3 Technology 12.29%
4 Energy 11.45%
5 Industrials 11.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
1
Pfizer
PFE
$144B
$285M 4.39%
10,118,939
+2,182,146
+27% +$62.2M
GE icon
2
GE Aerospace
GE
$368B
$242M 3.73%
1,918,979
-63,496
-3% -$8.08M
ETN icon
3
Eaton
ETN
$142B
$238M 3.67%
3,085,340
-392,015
-11% -$29.1M
C icon
4
Citigroup
C
$216B
$224M 3.45%
4,749,601
+528,271
+13% +$25.1M
OXY icon
5
Occidental Petroleum
OXY
$55.6B
$189M 2.91%
1,922,348
-47,019
-2% -$4.42M
AAPL icon
6
Apple
AAPL
$5T
$182M 2.8%
7,814,292
-2,035,156
-21% -$43.3M
CVA
7
DELISTED
Covanta Holding Corporation
CVA
$179M 2.76%
8,688,832
+3,475,131
+67% +$65.7M
EMC
8
DELISTED
EMC CORPORATION
EMC
$162M 2.5%
6,162,590
+1,610,041
+35% +$42.5M
ALL icon
9
Allstate
ALL
$70.9B
$159M 2.46%
2,714,687
+178,731
+7% +$10.3M
MRK icon
10
Merck
MRK
$322B
$139M 2.14%
2,519,906
-1,691,812
-40% -$92.3M
PF
11
DELISTED
Pinnacle Foods, Inc.
PF
$139M 2.14%
4,211,488
-466,442
-10% -$14.7M
WFC icon
12
Wells Fargo
WFC
$260B
$131M 2.03%
2,500,499
-21,471
-0.9% -$1.08M
CMCSA icon
13
Comcast
CMCSA
$86.8B
$128M 1.98%
4,786,398
+4,007,984
+515% +$103M
HOLX
14
DELISTED
Hologic
HOLX
$121M 1.86%
4,755,399
-1,267,511
-21% -$29.6M
JPM icon
15
JPMorgan Chase
JPM
$931B
$116M 1.79%
2,010,343
+61,316
+3% +$3.45M
BIO icon
16
Bio-Rad Laboratories Class A
BIO
$8.88B
$114M 1.76%
953,801
-2,068
-0.2% -$253K
ORCL icon
17
Oracle
ORCL
$339B
$114M 1.75%
2,804,671
+50,692
+2% +$2.09M
MDT icon
18
Medtronic
MDT
$112B
$113M 1.74%
1,772,634
+1,695,709
+2,204% +$103M
GM icon
19
General Motors
GM
$81.9B
$107M 1.65%
2,942,968
+1,517,595
+106% +$52.9M
WMB icon
20
Williams Companies
WMB
$86.3B
$101M 1.56%
1,735,473
+302,865
+21% +$14M
NOV icon
21
NOV
NOV
$7B
$94.6M 1.46%
+1,149,097
New +$85.6M
CB icon
22
Chubb
CB
$141B
$84.4M 1.3%
814,068
+141,588
+21% +$14.5M
VZ icon
23
Verizon
VZ
$200B
$81.7M 1.26%
1,668,839
-213,989
-11% -$10.4M
CAM
24
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$81.5M 1.26%
1,203,126
-1,015,192
-46% -$65.4M
JNJ icon
25
Johnson & Johnson
JNJ
$642B
$80.1M 1.24%
765,741
-14,040
-2% -$1.42M

Similar funds

Levin Capital Strategies's Q2 2014 Portfolio in Review

As of Q2 2014, Levin Capital Strategies held 398 positions worth $6.49B, up 8.7% from $5.97B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Levin Capital Strategies deployed $250M of net new capital in Q2 2014, opening 73 new positions and adding to 93 existing holdings. Its largest new stake was NOV: 1,149,097 shares worth $94.6M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was WPX Energy, Inc., an estimated $114M trimmed.

  • Levin Capital Strategies's largest Q2 2014 buy was NOV: 1,149,097 shares worth $94.6M.
  • Levin Capital Strategies added most to Medtronic in Q2 2014, an estimated $103M increase.
  • Levin Capital Strategies's biggest Q2 2014 reduction was WPX Energy, Inc., cutting an estimated $114M.
  • Levin Capital Strategies fully exited Molson Coors Class B in Q2 2014, selling an estimated $60.9M.
  • Levin Capital Strategies's ten largest holdings make up 31% of its $6.49B portfolio in Q2 2014.
  • Levin Capital Strategies opened 73 new positions and closed 53 in Q2 2014.
  • Levin Capital Strategies's portfolio value rose 8.7% quarter-over-quarter to $6.49B.

Based on Levin Capital Strategies's 13F filing for Q2 2014, filed 13 Aug 2014.